News

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Crown Holdings Inc (Symbol: CCK), where a total of 8,572 contracts have traded so far, representing approximately 857,200 underlying shares. That amounts to about 61.9% of CCK's average daily trading volume over the past month of 1.4 million shares. Especially high volume was seen for the $82.50 strike put option expiring February 16, 2024, with 4,000 contracts trading so far today, representing approximately 400,000 underlying shares of CCK. Below is a chart showing CCK's trailing twelve month trading history, with the $82.50 strike highlighted in orange:

TD SYNNEX Corp (Symbol: SNX) options are showing a volume of 6,074 contracts thus far today. That number of contracts represents approximately 607,400 underlying shares, working out to a sizeable 59.2% of SNX's average daily trading volume over the past month, of 1.0 million shares. Particularly high volume was seen for the $95 strike put option expiring March 15, 2024, with 1,832 contracts trading so far today, representing approximately 183,200 underlying shares of SNX. Below is a chart showing SNX's trailing twelve month trading history, with the $95 strike highlighted in orange:

And Biogen Inc (Symbol: BIIB) saw options trading volume of 5,437 contracts, representing approximately 543,700 underlying shares or approximately 58.8% of BIIB's average daily trading volume over the past month, of 924,940 shares. Particularly high volume was seen for the $250 strike call option expiring February 16, 2024, with 1,303 contracts trading so far today, representing approximately 130,300 underlying shares of BIIB. Below is a chart showing BIIB's trailing twelve month trading history, with the $250 strike highlighted in orange:

For the various different available expirations for CCK options, SNX options, or BIIB options, visit StockOptionsChannel.com.

STKL Insider Buying
COF Options Chain
REVB market cap history

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.